AS-S603

· Amyloid Solution Inc

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for AS-S603, covering 2025-05-28 to 2025-05-28. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 1 Clinical Trial to Investigate the Safety, Tolerability, and Pharmacokinetics of AS-S603 in Healthy Participants [Phase 1]

See pricing